Neurosci Lett 658:3236 Kiasalari Z, Afshin-Majd S, Baluchnejadmojarad T, Azadi-Ahmadabadi E, Fakour M, Ghasemi-Tarie R, Jalalzade-Ogvar S, Khodashenas V, Tashakori-Miyanroudi M, Roghani M (2021) Sinomenine alleviates murine experimental autoimmune encephalomyelitis model of multiple sclerosis through inhibiting NLRP3 inflammasome
Oral GLP-1 medicines are available for weight management, including orforglipron (Foundayo), approved by the FDA in April 2026, and an oral form of semaglutide
Transfection was performed in triplicates with 10 g of each plasmid (GFP and MS4A15) using Lipofectamine 2000 following the manufacturers instructions
Funding was from the Medical Research Council, as part of United Kingdom Research and Innovation (also known as UK Research and Innovation), (File reference number MC_U105178783)